Increase in prevalence of autoimmune diseases, rise in technological advancements, and rise in awareness about early diagnosis are the major factors which drive the global market growth. Increasing ...

The autoimmune testing landscape is shifting from single-analyte assays toward multiplex, high-sensitivity platforms capable of detecting multiple biomarkers from a single sample. Laboratories are ...

Exagen Inc. has reached a major milestone by completing its 1,000,000th AVISE CTD test, a diagnostic tool for autoimmune and connective tissue diseases. This achievement highlights the company’s ...

DUBLIN--(BUSINESS WIRE)--The "Autoimmune Disease Diagnostics Market (By Disease, Test Types, Country Analysis), Key Company Profiles, Strategy, Financial Insights, Recent Developments - Forecast to ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. “We've always said that acquiring local laboratories or ...

A research team from the University of Oklahoma Health Sciences Center, led by Madeleine Cunningham, Ph.D., in conjunction with the National Institute of Mental Health (NIMH), has developed the ...

Add Yahoo as a preferred source to see more of our stories on Google. Autoimmune diseases are on the rise. It’s not just a hunch—autoimmune diseases are rising sharply, and the numbers are too ...

Autoimmune rheumatic diseases (ARDs) represent a diverse group of conditions in which the immune system mistakenly targets the body’s own tissues, often affecting the musculoskeletal system and ...

The MarketWatch News Department was not involved in the creation of this content. CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire select operating assets and ...

But for some people, they could be early signs of a rare condition called autoimmune encephalitis. This is when the body’s ...

The global autoimmune disease testing market is witnessing steady expansion as healthcare systems intensify focus on early diagnosis and chronic disease management. Valued at USD 4.94 billion in 2025, ...